Advanced Biomaterial-Based In Vitro Osteoarthritis Models: Integrating Sex as a Biological Variable in Hormonal, Subchondral Bone, and Mechanobiological Pathways
Source abstract
Abstract
Osteoarthritis (OA) is the most common form of arthritis and represents a major clinical and socioeconomic burden. Epidemiological data consistently show that OA affects women more frequently and, in several joints, more severely than men. Nevertheless, current in vitro models rarely consider sex-specific variables, limiting their ability to capture the biological mechanisms that shape the pathogenesis and progression of OA. Increasing evidence indicates that age-related hormonal fluctuations and subchondral bone remodeling strongly influence OA evolution, and that these processes differ between the sexes. For instance, the decline in estrogen levels during menopause has been associated with accelerated cartilage degeneration, increased osteoclastic activity, and a higher susceptibility to subchondral bone alterations, which may contribute to more aggressive clinical manifestations in women. These mechanisms are only partially reproduced in widely used experimental systems, including traditional biomaterial scaffolds and simplified osteochondral constructs, leaving important sex-dependent pathways unresolved. While advanced biomaterials enable precise control of stiffness, porosity, and biochemical cues, most current in vitro OA models still rely on sex-neutral design assumptions, limiting their ability to reproduce the divergent disease trajectories observed in men and women. By integrating material properties with dynamic loading and tunable hormonal conditions, next-generation in vitro systems could improve mechanistic understanding, increase the reliability of drug screening, and better support the development of sex-specific therapies through the combined efforts of bioengineering, materials science, cell biology, and translational medicine.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Bone health and osteoporosis research · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Engineering, University of Palermo, Viale delle Scienze, Ed. 8, 90128 Palermo, Italy
CS-Surgical Sciences and Technologies-SS Omics Science Platform for Personalized Orthopedics, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy
Funding
Finanziamenti da bandi Ministeriali e altri EEPP
References (100+)
Show source-provided references
1. Osteoarthritis10.1038/s41572-025-00594-6 ↗
2. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: A systematic analysis for the Global Burden of Disease Study 202110.1016/S2665-9913(23)00163-7 ↗
3. Knee osteoarthritis rehabilitation: An integrated framework of exercise, nutrition, biomechanics, and physical therapist guidance-a narrative review10.1186/s40001-025-03083-4 ↗
4. Alternative and complementary therapies in osteoarthritis and cartilage repair10.1007/s40520-020-01515-1 ↗
5. Kartogenin (KGN)/synthetic melanin nanoparticles (SMNP) loaded theranostic hydrogel scaffold system for multiparametric magnetic resonance imaging guided cartilage regeneration10.1002/btm2.10364 ↗
6. Contartese, D., Tschon, M., De Mattei, M., and Fini, M. (2020). Sex Specific Determinants in Osteoarthritis: A Systematic Review of Preclinical Studies. Int. J. Mol. Sci., 21.10.3390/ijms21103696 ↗
7. Osteoarthritis in people over 16: Diagnosis and management-updated summary of NICE guidance10.1136/bmj.p24 ↗
8. Italian Orthopaedic and Traumatology Society (SIOT) position statement on the non-surgical management of knee osteoarthritis10.1186/s10195-023-00729-z ↗
9. Estrogen receptor is involved in the osteoarthritis mediated by Atg16L1-NLRP3 activation10.52312/jdrs.2024.1247 ↗
10. Tschon, M., Contartese, D., Pagani, S., Borsari, V., and Fini, M. (2021). Gender and Sex Are Key Determinants in Osteoarthritis Not Only Confounding Variables. A Systematic Review of Clinical Data. J. Clin. Med., 10.10.3390/jcm10143178 ↗
11. The role of mechanobiology in bone and cartilage model systems in characterizing initiation and progression of osteoarthritis10.1063/5.0068277 ↗
12. Farkouh, A., Baumgärtel, C., Gottardi, R., Hemetsberger, M., Czejka, M., and Kautzky-Willer, A. (2021). Sex-Related Differences in Drugs with Anti-Inflammatory Properties. J. Clin. Med., 10.10.3390/jcm10071441 ↗
13. Antinociception produced by nonsteroidal anti-inflammatory drugs in female vs male rats10.1097/FBP.0000000000000584 ↗
14. Mei, Y., Williams, J.S., Webb, E.K., Shea, A.K., MacDonald, M.J., and Al-Khazraji, B.K. (2022). Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review. Front. Rehabil. Sci., 3.10.3389/fresc.2022.825147 ↗
15. Mechanical Articular Cartilage Injury Models and Their Relevance in Advancing Therapeutic Strategies10.1007/978-3-031-25588-5_8 ↗
16. Zhu, T., Zhou, H., Chen, X., and Zhu, Y. (2023). Recent advances of responsive scaffolds in bone tissue engineering. Front. Bioeng. Biotechnol., 11.10.3389/fbioe.2023.1296881 ↗
17. Osteoarthritis: Pathogenic signaling pathways and therapeutic targets10.1038/s41392-023-01330-w ↗
18. Closing the gap: Sex-related differences in osteoarthritis and the ongoing need for translational studies10.21037/atm-23-1546 ↗
19. Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women’s Health Across the Nation10.1210/jc.2016-4017 ↗
20. The endocrinology of the menopause10.1016/S0960-0760(98)00145-9 ↗
21. Franke, M., Mancino, C., and Taraballi, F. (2023). Reasons for the Sex Bias in Osteoarthritis Research: A Review of Preclinical Studies. Int. J. Mol. Sci., 24.10.3390/ijms241210386 ↗
22. Gender-differences in imaging phenotypes of osteoarthritis in the osteoarthritis initiative10.1038/s41598-025-90782-x ↗
23. Estrogen receptor Alpha in human knee articular cartilage of healthy and osteoarthritic females10.1016/j.jor.2021.08.005 ↗
24. Low back pain and osteoarthritis pain: A perspective of estrogen10.1038/s41413-023-00280-x ↗
25. Xu, J.Y., O’Connell, M.A., Notini, L., Cheung, A.S., Zwickl, S., and Pang, K.C. (2021). Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care?. Front. Endocrinol., 12.10.3389/fendo.2021.701364 ↗
26. ERs associate with and regulate the production of caveolin: Implications for signaling and cellular actions10.1210/mend.16.1.0757 ↗
27. The involvement of signaling pathways in the pathogenesis of osteoarthritis: An update
28. Mechanotransduction pathways in articular chondrocytes and the emerging role of estrogen receptor-α10.1038/s41413-023-00248-x ↗
29. Veronesi, F., Contartese, D., Borsari, V., Pagani, S., Fini, M., De Mattei, M., and Tschon, M. (2022). Ageing and Osteoarthritis Synergically Affect Human Synoviocyte Cells: An In Vitro Study on Sex Differences. J. Clin. Med., 11.10.3390/jcm11237125 ↗
30. Liu, J., Xu, T., Ma, L., and Chang, W. (2021). Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer. Front. Oncol., 11.10.3389/fonc.2021.593479 ↗
31. Taheri, M., Shoorei, H., Dinger, M.E., and Ghafouri-Fard, S. (2020). Perspectives on the Role of Non-Coding RNAs in the Regulation of Expression and Function of the Estrogen Receptor. Cancers, 12.10.3390/cancers12082162 ↗
32. Choi, M.C., Jo, J., Park, J., Kang, H.K., and Park, Y. (2019). NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction. Cells, 8.10.3390/cells8070734 ↗
33. Shigehara, K., Izumi, K., Kadono, Y., and Mizokami, A. (2021). Testosterone and Bone Health in Men: A Narrative Review. J. Clin. Med., 10.10.3390/jcm10030530 ↗
34. Lower serum testosterone is associated with increased likelihood of arthritis10.1038/s41598-023-46424-1 ↗
35. Ma, N., and Gao, F. (2025). Correlation between low testosterone levels and the risk of osteoarthritis: A cross-sectional analysis of NHANES data (2011–2016). BMC Musculoskelet. Disord., 26.10.1186/s12891-024-08272-6 ↗
36. Testosterone Delays Bone Microstructural Destruction via Osteoblast-Androgen Receptor-Mediated Upregulation of Tenascin-C10.1002/advs.202501518 ↗
37. A Review on Testosterone: Estradiol Ratio-Does It Matter, How Do You Measure It, and Can You Optimize It?10.5534/wjmh.240029 ↗
38. Sex Differences in Gene Expression and Regulatory Networks across 29 Human Tissues10.1016/j.celrep.2020.107795 ↗
39. Prevalence and factors associated with knee osteoarthritis among middle-aged and elderly individuals in rural Tianjin: A population-based cross-sectional study10.1186/s13018-023-03742-4 ↗
40. Role and Mechanism of Mechanical Load in the Homeostasis of the Subchondral Bone in Knee Osteoarthritis: A Comprehensive Review10.2147/JIR.S492415 ↗
41. Biochemical and Morphological Abnormalities of Subchondral Bone and Their Association with Cartilage Degeneration in Spontaneous Osteoarthritis10.1007/s00223-021-00834-3 ↗
42. Estrogen Modulates Cartilage and Subchondral Bone Remodeling in an Ovariectomized Rat Model of Postmenopausal Osteoarthritis10.12659/MSM.916254 ↗
43. Disentangling the molecular interplays between subchondral bone and articular cartilage in estrogen deficiency-induced osteoarthritis10.1016/j.joca.2022.09.006 ↗
44. Increased Sparc release from subchondral osteoblasts promotes articular chondrocyte degeneration under estrogen withdrawal10.1016/j.joca.2022.08.020 ↗
45. Bone mineral density changes during the menopause transition in a multiethnic cohort of women10.1210/jc.2007-1876 ↗
46. Hormones and bone loss across the menopause transition10.1016/bs.vh.2020.12.016 ↗
47. Thapa, S., Nandy, A., and Rendina-Ruedy, E. (2022). Endocrinal metabolic regulation on the skeletal system in post-menopausal women. Front. Physiol., 13.10.3389/fphys.2022.1052429 ↗
48. Changes of the subchondral bone microchannel network in early osteoarthritis10.1016/j.joca.2022.10.002 ↗
49. Elastin dose-controlled mineral deposition by masking collagen-binding sites for calcium ions10.1016/j.ijbiomac.2025.143270 ↗
50. Zhu, X., Chan, Y.T., Yung, P.S.H., Tuan, R.S., and Jiang, Y. (2020). Subchondral Bone Remodeling: A Therapeutic Target for Osteoarthritis. Front. Cell Dev. Biol., 8.10.3389/fcell.2020.607764 ↗
51. Towards sex-specific osteoarthritis risk models: Evaluation of risk factors for knee osteoarthritis in males and females10.1093/rheumatology/keab378 ↗
52. Tibial subchondral trabecular bone micromechanical and microarchitectural properties are affected by alignment and osteoarthritis stage10.1038/s41598-020-60464-x ↗
53. Menopause-Related Changes in Body Composition Are Associated With Subsequent Bone Mineral Density and Fractures: Study of Women’s Health Across the Nation10.1002/jbmr.4759 ↗
54. Clinical and omics biomarkers in osteoarthritis diagnosis and treatment
55. Identification of diagnostic biomarkers for osteoarthritis through bioinformatics and machine learning10.1016/j.heliyon.2024.e27506 ↗
56. Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition10.1210/clinem/dgad727 ↗
57. The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort10.1016/j.joca.2019.12.012 ↗
58. Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update10.2147/CIA.S242288 ↗
59. Alendronate inhibits osteocyte apoptosis and inflammation via IL-6, inhibiting bone resorption in periapical lesions of ovariectomized rats10.1111/iej.13206 ↗
60. Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models10.1186/s13075-022-02961-0 ↗
61. Do we understand sex-related differences governing dimorphic disease mechanisms in preclinical animal models of osteoarthritis?10.1016/j.joca.2024.03.113 ↗
62. Uncovering the “riddle of femininity” in osteoarthritis: A systematic review and meta-analysis of menopausal animal models and mathematical modeling of estrogen treatment10.1016/j.joca.2022.12.009 ↗
63. Knee osteoarthritis: Key treatments and implications for physical therapy10.1016/j.bjpt.2020.08.004 ↗
64. Combined effect of physical exercise and hormone replacement therapy on cardiovascular and metabolic health in postmenopausal women: A systematic review and meta-analysis10.1590/1414-431x2023e12241 ↗
65. Does Menopausal Hormone Therapy, Exercise, or Both Improve Pain and Function in Postmenopausal Women With Greater Trochanteric Pain Syndrome? A 2 × 2 Factorial Randomized Clinical Trial10.1177/03635465211061142 ↗
66. Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: A propensity-matched retrospective cohort study of 1,779 patients10.1016/j.jseint.2025.04.022 ↗
67. Hormone Replacement Therapy Does Not Eliminate Risk Factors for Joint Complications following Total Joint Arthroplasty: A Matched Cohort Study10.3390/pathophysiology30020011 ↗
68. Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: Primary report from the HOPE-e randomised, placebo-controlled, feasibility study10.1016/S2665-9913(22)00218-1 ↗
69. Management of Osteoarthritis: Expert Opinion on NSAIDs10.1007/s40122-021-00260-1 ↗
70. Association of hormone replacement therapy and the risk of knee osteoarthritis: A meta-analysis10.1097/MD.0000000000032466 ↗
71. Novel Advances in the Role of Selective Estrogen Receptor Modulators in Hormonal Replacement Therapy: A Paradigm Shift
72. Selective estrogen receptor modulators and bone health10.1080/13697137.2021.1936485 ↗
73. Association between testosterone levels and bone mineral density in females aged 40–60 years from NHANES 2011–201610.1038/s41598-022-21008-7 ↗
74. Belluti, S., Imbriano, C., and Casarini, L. (2023). Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function. Cancers, 15.10.3390/cancers15184653 ↗
75. Jensen, C., and Teng, Y. (2020). Is It Time to Start Transitioning From 2D to 3D Cell Culture?. Front. Mol. Biosci., 7.10.3389/fmolb.2020.00033 ↗
76. Xu, L., Kazezian, Z., Pitsillides, A.A., and Bull, A.M.J. (2024). A synoptic literature review of animal models for investigating the biomechanics of knee osteoarthritis. Front. Bioeng. Biotechnol., 12.10.3389/fbioe.2024.1408015 ↗
77. Animal Models of Osteoarthritis: Updated Models and Outcome Measures 2016–202310.1007/s40883-023-00309-x ↗
78. Replacing Animal Testing with Stem Cell-Organoids: Advantages and Limitations10.1007/s12015-024-10723-5 ↗
79. Ferraz, M.P. (2024). An Overview on the Big Players in Bone Tissue Engineering: Biomaterials, Scaffolds and Cells. Int. J. Mol. Sci., 25.10.3390/ijms25073836 ↗
80. Articular cartilage repair biomaterials: Strategies and applications10.1016/j.mtbio.2024.100948 ↗
81. Advances in organ-on-a-chip systems for modelling joint tissue and osteoarthritic diseases10.1016/j.joca.2022.03.012 ↗
82. Integration of clinical perspective into biomimetic bioreactor design for orthopedics10.1002/jbm.b.34929 ↗
83. Fu, J., Wang, X., Yang, M., Chen, Y., Zhang, J., Deng, R., Zhang, Z., Yu, J., and Yuan, F. (2022). Scaffold-Based Tissue Engineering Strategies for Osteochondral Repair. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.812383 ↗
84. Yan, X., Chen, Y.R., Song, Y.F., Yang, M., Ye, J., Zhou, G., and Yu, J.K. (2019). Scaffold-Based Gene Therapeutics for Osteochondral Tissue Engineering. Front. Pharmacol., 10.10.3389/fphar.2019.01534 ↗
85. Osteochondral Tissue Engineering: Scaffold Materials, Fabrication Techniques and Applications10.1002/biot.202400699 ↗
86. Advances in electrospinning and 3D bioprinting strategies to enhance functional regeneration of skeletal muscle tissue10.1016/j.bioadv.2022.213135 ↗
87. Crouch, D.J., Sheridan, C.M., Behnsen, J.G., D’Sa, R.A., and Bosworth, L.A. (2023). Cryo-Electrospinning Generates Highly Porous Fiber Scaffolds Which Improves Trabecular Meshwork Cell Infiltration. J. Funct. Biomater., 14.10.3390/jfb14100490 ↗
88. Enhancement of the chondrogenic differentiation capacity of human dental pulp stem cells via chondroitin sulfate-coated polycaprolactone-MWCNT nanofibers10.1038/s41598-024-66497-w ↗
89. Development of Tri-Layered Biomimetic Atelocollagen Scaffolds with Interfaces for Osteochondral Tissue Engineering10.1002/adhm.202101643 ↗
90. Jahangir, S., Vecstaudza, J., Augurio, A., Canciani, E., Stipniece, L., Locs, J., Alini, M., and Serra, T. (2023). Cell-Laden 3D Printed GelMA/HAp and THA Hydrogel Bioinks: Development of Osteochondral Tissue-like Bioinks. Materials, 16.10.3390/ma16227214 ↗
91. Design of graded biomimetic osteochondral composite scaffolds10.1016/j.biomaterials.2008.05.008 ↗
92. Tuning the biomimetic behavior of scaffolds for regenerative medicine through surface modifications10.1002/term.2859 ↗
93. Extracellular matrix matters: Matrix-based bioscaffolds in advancing translational cancer research and targeted therapy10.1152/ajpcell.00050.2025 ↗
94. A new bi-layered scaffold for osteochondral tissue regeneration: In vitro and in vivo preclinical investigations10.1016/j.msec.2016.08.027 ↗
95. Sex as a biological variable: A contemporary perspective10.1016/j.ahj.2025.03.012 ↗
96. The Sex Inclusive Research Framework to address sex bias in preclinical research proposals10.1038/s41467-025-58560-5 ↗
97. Sex omission and male bias are still widespread in cell experiments10.1152/ajpcell.00358.2020 ↗
98. Three-dimensional (3D) polylactic acid gradient scaffold to study the behavior of osteosarcoma cells under dynamic conditions10.1002/jbm.a.37665 ↗
99. Human nasoseptal chondrocytes maintain their differentiated phenotype on PLLA scaffolds produced by thermally induced phase separation and supplemented with bioactive glass 139310.1080/03008207.2018.1539083 ↗
100. A Col I and BCP ceramic bi-layer scaffold implant promotes regeneration in osteochondral defects10.1039/C8RA09171D ↗